Display Settings:

Format

Send to:

Choose Destination
    Antimicrob Agents Chemother. 2004 May;48(5):1908-11.

    Novel inhalational murine model of invasive pulmonary aspergillosis.

    Source

    St. John's Cardiovascular Research Center, Division of Infectious Diseases, Department of Medicine, Harbor-UCLA Research and Education Institute, Torrance, California 90502, USA.

    Abstract

    We developed a novel model of invasive aspergillosis (IA) that recapitulates human disease. Mice were immunosuppressed with cyclophosphamide and cortisone acetate and then infected in an aerosol chamber. This procedure reproducibly delivered 1 x 10(3) to 3 x 10(3) conidia to the lungs. Lethal pulmonary IA developed over 2 weeks and was prevented by amphotericin B.

    PMID:
    15105158
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC400587
    Free PMC Article

    Images from this publication.See all images (5) Free text

    FIG. 2.
    FIG. 4.
    FIG. 1.
    FIG. 3.
    FIG. 5.

      Supplemental Content

      Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk